O'Hara Elaine 4
4 · NOVAVAX INC · Filed Mar 5, 2026
Insider Transaction Report
Form 4
NOVAVAX INCNVAX
O'Hara Elaine
EVP, Chief Strategy Officer
Transactions
- Exercise/Conversion
Common Stock
2026-03-03+56,334→ 157,071 total - Tax Payment
Common Stock
[F1]2026-03-03$9.49/sh−22,429$212,851→ 134,642 total - Exercise/Conversion
Restricted Stock Units
[F2]2026-03-03−56,334→ 112,666 totalExercise: $0.00Exp: 2035-03-03→ Common Stock (56,334 underlying)
Footnotes (2)
- [F1]Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting.
- [F2]One-third (1/3) of the RSUs subject to this grant under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, vest on each of the first three (3) anniversaries of March 3, 2025, in each case subject to continued employment through such vesting date.
Signature
/s/ Mark J. Casey, Attorney-in-Fact|2026-03-05